UMB Bank’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.7K Buy
2,646
+25
+1% +$793 ﹤0.01% 1161
2026
Q1
$82.5K Buy
2,621
+69
+3% +$2.17K ﹤0.01% 1053
2025
Q4
$75.2K Buy
+2,552
New +$70.9K ﹤0.01% 1076
2024
Q2
– Sell
-199
Closed -$6K – 2204
2024
Q1
$6K Buy
+199
New +$5.52K ﹤0.01% 1360
2023
Q4
– Sell
-272
Closed -$10.1K – 1730
2023
Q3
$10.1K Hold
272
– – ﹤0.01% 1288
2023
Q2
$10.6K Hold
272
– – ﹤0.01% 1287
2023
Q1
$9.93K Buy
+272
New +$8.59K ﹤0.01% 1295

Other funds holding RTO

UMB Bank's RTO Position: Q2 2026 in Review

UMB Bank increased its Rentokil (RTO) stake by 0.95% in Q2 2026, buying an estimated $793 and bringing the position to 2,646 shares worth $75.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

UMB Bank first reported a position in RTO in Q1 2023 and has held it in 7 quarters since. The position peaked at $82.5K in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • UMB Bank held 2,646 shares of Rentokil worth $75.7K as of Q2 2026.
  • UMB Bank bought 25 Rentokil shares in Q2 2026, an estimated $793.
  • Rentokil made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1161 holding.
  • UMB Bank first reported a position in Rentokil in Q1 2023 and has held it in 7 quarters since.
  • UMB Bank's Rentokil position peaked at $82.5K in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.